畜牧兽医学报 ›› 2025, Vol. 56 ›› Issue (3): 1065-1075.doi: 10.11843/j.issn.0366-6964.2025.03.009

• 综述 • 上一篇    下一篇

水杨酰苯胺类及咪唑并噻唑类抗寄生虫药物的理化性质及其应用研究进展

代国年1,2(), 李冰1, 周雅馨1, 李江1, 徐晶1, 周绪正1, 彭晓婷3, 张继瑜1,2,*()   

  1. 1. 中国农业科学院兰州畜牧与兽药研究所, 兰州 730050
    2. 甘肃农业大学, 兰州 730070
    3. 中牧实业股份有限公司兰州生物药厂, 兰州 730046
  • 收稿日期:2024-05-07 出版日期:2025-03-23 发布日期:2025-04-02
  • 通讯作者: 张继瑜 E-mail:dai940910@163.com;infzjy@sina.com
  • 作者简介:代国年(1994-),男,甘肃张掖人,博士,主要从事兽医药理学与毒理学研究,E-mail: dai940910@163.com
  • 基金资助:
    甘肃省科技计划项目--科技重大专项计划(23ZDFA001);甘肃省科技计划项目--重点研发计划(23YFNA0001);国家肉牛牦牛产业技术体系(CARS-37)

Research Progress on The Physicochemical Properties and Applications of Salicylanilines and Imidazolothiazole Antiparasitic Drugs

DAI Guonian1,2(), LI Bing1, ZHOU Yaxin1, LI Jiang1, XU Jing1, ZHOU Xuzheng1, PENG Xiaoting3, ZHANG Jiyu1,2,*()   

  1. 1. Lanzhou Institute of Animal Husbandry and Veterinary Medicine, Chinese Academy of Agricultural Sciences, Lanzhou 730050, China
    2. Gansu Agricultural University, Lanzhou 730070, China
    3. Lanzhou Biopharmaceutical Factory of Zhongmu Industry Co., Ltd, Lanzhou 730046, China
  • Received:2024-05-07 Online:2025-03-23 Published:2025-04-02
  • Contact: ZHANG Jiyu E-mail:dai940910@163.com;infzjy@sina.com

摘要:

寄生虫病严重制约畜牧业的发展,由于治疗药物种类较少等问题导致耐药性严重,且治疗效果不佳,因此近年来对于有效防治寄生虫病的新型药物需求增加。针对当前现状,大量临床试验表明:将两种或多种抗寄生虫类药物联用,可能会达到增强药物利用度、扩大抗虫谱并降低寄生虫耐药性的目的。为此,将隶属于咪唑并噻唑类药物的盐酸左旋咪唑和隶属于水杨酰苯胺类药物的羟氯扎胺联合使用,可有效防治线虫病和吸虫病,其独特的作用机理引起了研究者广泛的关注。本文就这两类药物的作用机理、设计合成、理化性质、研究现状以及联合使用的疗效等进行综述。

关键词: 寄生虫, 水杨酰苯胺类, 咪唑并噻唑类, 盐酸左旋咪唑, 羟氯扎胺, 疗效

Abstract:

Parasitic diseases significantly hinder the development of animal husbandry. The limited range of therapeutic drugs has led to severe drug resistance and suboptimal treatment outcomes. Consequently, there has been an increased demand for new drugs effective in preventing and treating parasitic diseases. In response, numerous clinical trials demonstrate that combining two or more antiparasitic drugs can enhance efficacy, broaden the antiparasitic spectrum, and mitigate parasite resistance. The combination of levamisole hydrochloride, an imidazole thiazole drug, and oxyclozanide, a salicylamide drug, has proven effective in treating nematode and schistosomiasis, with its unique mechanism of action garnering extensive researcher interest. This article provides a comprehensive review of the mechanisms of action, design and synthesis, physicochemical properties, research status, and therapeutic efficacy of these dual-class drug combinations.

Key words: parasites, salicylanilines, imidazolothiazoles, levamisole hydrochloride, oxyclozanide, efficacy

中图分类号: